Pharma Journalist - Page 911 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

ViraCyte Granted U.S. FDA Fast Track Designation for Viralym-C

Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in China

Pure MHC to Partner with AbbVie on Oncology Research

Takeda to Acquire ARIAD Pharmaceuticals, Inc. for $5.2 Billion

Zebra Biologics Inc. to Collaborate with AbbVie to Discover New Antibody Therapeutics

Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

Enzyvant to Develop Novel Biologic Therapy for Complete DiGeorge Syndrome

Mast Therapeutics And Savara Sign Merger Agreement

Ambrx and MabSpace Biosciences to Collaborate on Novel Antibody Drug Conjugates

Takeda Pharmaceutical and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease